Toward an HDAC6 inhibitor: synthesis and conformational analysis of cyclic hexapeptide hydroxamic acid designed from α-tubulin sequence
- 15 March 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 12 (6) , 1351-1356
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Mass spectrometric determination of amino acid sequence in Cyl-2, a novel cyclotetrapeptide from Cylindrocladium scopariumJournal of Mass Spectrometry, 2005
- Deacetylase EnzymesChemistry & Biology, 2002
- Functional significance of histone deacetylase diversityCurrent Opinion in Genetics & Development, 2001
- Histone Deacetylase: A Target for Antiproliferative and Antiprotozoal AgentsCurrent Medicinal Chemistry, 2001
- Acetylation: a regulatory modification to rival phosphorylation?The EMBO Journal, 2000
- Histone acetylases and deacetylases in cell proliferationCurrent Opinion in Genetics & Development, 1999
- Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACsCurrent Opinion in Chemical Biology, 1997
- Apicidin: A novel antiprotozoal agent that inhibits parasite histone deacetylaseProceedings of the National Academy of Sciences, 1996
- FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. III. Antitumor activities on experimental tumors in mice.The Journal of Antibiotics, 1994
- FR901228, a novel antitumor bicyclic depsipeptide produced by chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity.The Journal of Antibiotics, 1994